Educational Objectives

 Evaluate the benefits of risk factor reduction on CV outcomes in
 Type 2 diabetes:
 Glucose control.
 Hypertension management.
 Achieving lipid goals.
 Weight management.

 Discuss and interpret updates on clinical trials in Type 2 diabetes:
 PROACTIVE.
 FIELD.
 CARDS.
 CHICAGO.

 Discuss advances in non-invasive imaging in patients with Type 2
 diabetes such as carotidintima-media thickness (IMT).

 Discuss recent advances in the management of dyslipidemia in
 patients with metabolic syndrome by not Type 2 diabetes.

 Discuss the management of edema in patients with Type 2 diabetes
 on thiazolidinediones and other anti-diabetic medications.

 Evaluate the benefits of risk factor reduction on CV outcomes in
 Type 2 diabetes:
 Type 2 diabetes with dyslipidemia.
 Type 2 diabetes with acute coronary syndromes.
 Type 2 diabetes with uncontrolled hyperglycemia.
 Type 2 diabetes with edema on a thiazolidinedione.

This edition is for information and study purposes only as the CME credits have expired.

Back to Complex Lipid Management